Original Article

You have free access to this content

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  1. Chris H. Polman MD, PhD1,*,
  2. Stephen C. Reingold PhD2,
  3. Gilles Edan MD3,
  4. Massimo Filippi MD4,
  5. Hans-Peter Hartung MD5,
  6. Ludwig Kappos MD6,
  7. Fred D. Lublin MD7,
  8. Luanne M. Metz MD8,
  9. Henry F. McFarland MD9,
  10. Paul W. O'Connor MD10,
  11. Magnhild Sandberg-Wollheim MD11,
  12. Alan J. Thompson MD12,
  13. Brian G. Weinshenker MD13,
  14. Jerry S. Wolinsky MD14

Article first published online: 10 NOV 2005

DOI: 10.1002/ana.20703

Issue

Annals of Neurology

Annals of Neurology

Volume 58, Issue 6, pages 840–846, December 2005

Additional Information

How to Cite

Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H.-P., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., Sandberg-Wollheim, M., Thompson, A. J., Weinshenker, B. G. and Wolinsky, J. S. (2005), Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol., 58: 840–846. doi: 10.1002/ana.20703

Author Information

  1. 1

    Free University, Amsterdam, the Netherlands

  2. 2

    National Multiple Sclerosis Society and Scientific and Clinical Review Associates, LLC, New York, NY

  3. 3

    Centre Hospitalier Regional Universitaire Rennes, Rennes, France

  4. 4

    Neuroimaging Research Unit, Department of Neurology, University Hospital San Raffaele, Milan, Italy

  5. 5

    Department of Neurology, Heinrich-Heine-Universität, Düsseldorf, Germany

  6. 6

    Departments of Neurology and Research, University Hospital, Basel, Switzerland

  7. 7

    Mount Sinai School of Medicine, New York, NY

  8. 8

    Foothills Medical Centre, Calgary, Alberta, Canada

  9. 9

    National Institute of Neurological Disorders and Stroke, Bethesda, MD

  10. 10

    St. Michael's Hospital, Toronto, Ontario, Canada

  11. 11

    University Hospital, Lund, Sweden

  12. 12

    Institute of Neurology, London, United Kingdom

  13. 13

    Mayo Clinic College of Medicine, Rochester, MN

  14. 14

    University of Texas Health Sciences Center, Houston, TX

*Department of Neurology, VU Medical Center Amsterdam, PO Box 7057, 1007 MB Amsterdam, the Netherlands

Publication History

  1. Issue published online: 28 NOV 2005
  2. Article first published online: 10 NOV 2005
  3. Manuscript Accepted: 3 SEP 2005
  4. Manuscript Revised: 24 AUG 2005
  5. Manuscript Received: 29 JUN 2005

Funded by

  • US National Multiple Sclerosis Society
  • Multiple Sclerosis International Federation
  • Multiple Sclerosis Society of Ireland

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (79K)

References

  • 1
    McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.
    Direct Link:
  • 2
    Johnson RT. Message from the editor. Ann Neurol 2004; 55: 1.
    Direct Link:
  • 3
    Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002; 52: 47–53.
    Direct Link:
  • 4
    CHAMPS Study Group. MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology 2002; 59: 998–1005.
  • 5
    Barkhof F, Rocca M, Francis G, et al. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta-1a. Ann Neurol 2003; 53: 718–724.
    Direct Link:
  • 6
    Tintoré M, Rovira A, Rio J, et al. New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode. Neurology 2003; 60: 27–30.
  • 7
    Dalton CM, Brex PA, Miszkiel KA, et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 2003; 53: 673–676.
    Direct Link:
  • 8
    Dalton CM, Brex PS, Miszkiel KM, et al. Spinal cord MRI in clinically isolated optic neuritis. J Neurol Neurosurg Psychiatry 2003; 74: 1577–1580.
  • 9
    Frohman E, Goodin DS, Calabresi PA, et al. The utility of MRI in suspected MS. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003; 61: 602–611.
  • 10
    Bot JCJ, Barkhof F, Polman CH, et al. Spinal cord abnormalities in newly diagnosed MS patients: added value of spinal MRI examination. Neurology 2004; 62: 226–233.
  • 11
    Wolinsky JS, the PROMiSe Study Group. The diagnosis of primary progressive MS. J Neurol Sci 2003; 206: 145–152.
  • 12
    Polman CH, Wolinsky JS, Reingold SC. Multiple sclerosis diagnostic criteria: three years later. Mult Scler 2005; 11: 5–12.
  • 13
    Hahn CD, Shroff M, Blaser SI, et al. MRI criteria for multiple sclerosis: evaluation in a pediatric cohort. Neurology 2004; 62: 806–808.
  • 14
    Uitdehaag BMJ, Kappos L, Bauer L, et al. Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of MS: a proposal for standardization. Mult Scler 2005; 11: 227–231.
  • 15
    Paty DW, Noseworthy JH, Ebers GC. Diagnosis of MS. In: PatyDW, EbersGC, eds. Multiple sclerosis. Contemporary series; 50. Philadelphia: FA Davis Company, 1998; 55–85.
  • 16
    Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995; 13: 119–146.
  • 17
    Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107–1114.
  • 18
    Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG. The natural history of recurrent optic neuritis. Arch Neurol 2004; 61: 1401–1405.
  • 19
    Lennon V, Wingerchuk D, Kryzer T, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106–2112.
  • 20
    Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059–2069.
  • 21
    Tintoré M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 2000; 21: 702–706.
  • 22
    Uitdehaag BMJ, Geurts JJG, Barkhof F, Polman CH. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee. Neurology 2004; 63: 1140.
  • 23
    Filippi M. In-vivo tissue characterization of multiple sclerosis and other white matter diseases using magnetic resonance based techniques. J Neurol 2001; 248: 1019–1029.
  • 24
    Inglese M, Salvi F, Iannuci G, et al. Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. Am J Neuroradiol 2002; 23: 267–272.
  • 25
    Calabrese M, Ranzato F, Tiberio M, et al. The early MRI-based diagnosis of multiple sclerosis (McDonald Criteria): a prospective study in an homogeneous cohort of clinically isolated syndromes. Neurology 2004; 62(suppl 5): A293.
  • 26
    Longstreth WT, Arnold A, Beauchamp J, et al. Incidence, manifestations, and prediction of worsening white matter on serial cranial MRI in the elderly: the Cardiovascular Health Study. Stroke 2005; 36: 56–61.
  • 27
    Miller DH, Barkhof F, Berry I, et al. MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991; 54: 683–688.
  • 28
    Simon J, Li D, Traboulsee A, et al. Standardized MRI protocol for multiple sclerosis: Consortium of MS Centers (CMSC) consensus guidelines. Am J Neuroradiol (In Press).
  • 29
    Korteweg T, Barkhof F, Uitdehaag BMJ, Polman CH. How to use spinal cord magnetic resonance imaging in the McDonald diagnostic criteria for MS. Ann Neurol 2005; 57: 606–607.
    Direct Link:
  • 30
    Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. Findings in multiple sclerosis. Neurology 1993; 43: 2632–2637.
  • 31
    Bot JCJ, Barkhof F, Lycklama a Nijeholt G, et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 2002; 223: 46–56.
  • 32
    Lycklama G, Thompson A, Filippi M, et al. Spinal cord MRI in multiple sclerosis. Lancet Neurol 2003; 2: 555–562.
  • 33
    Brex P, O'Riordan J, Miszkiel K, et al. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology 1999; 53: 1184–1190.
  • 34
    Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000; 47: 831–835.
    Direct Link:
  • 35
    Rovaris M, Bozzali M, Santuccio G, et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001; 124: 2540–2549.
  • 36
    Andersson M, Alverez-Cermeno J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatr 1994; 57: 897–902.
  • 37
    Link H, Tibbling G. Principles of albumin and IgG analysis in neurological disorders. III. Validation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397–401.
  • 38
    Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Arch Neurol 2005; 865–870.
  • 39
    Chiappa KH. Use of evoked potentials for diagnosis of multiple sclerosis. Neurol Clin 1988; 6: 861–880.
  • 40
    HallidayAM, ed. Evoked potentials in clinical testing. 2nd ed. London: Churchill Livingstone, 1993.
View Full Article (HTML) Get PDF (79K)